CAMBRIDGE, MA, February 19, 2025 – OpenEvidence, the fastest-growing platform for doctors, has signed a multi-year content agreement with NEJM Group, publisher of the New England Journal of Medicine (NEJM). Under this agreement, all published content and multimedia from 1990 forward from NEJM, NEJM Evidence, NEJM AI, NEJM Catalyst, and NEJM Journal Watch will be provided to OpenEvidence to inform answers delivered on the OpenEvidence platform.
“In serving clinicians, it is crucial that the trusted evidence we publish informs clinical decisions," said David Sampson, Vice President and Chief Publishing Officer of NEJM Group. “OpenEvidence is emerging as a preferred resource for many clinicians. We are delighted to support OpenEvidence as a content partner, and we look forward to further collaborating with OpenEvidence to improve the delivery of clinical knowledge.”
“Information from trusted, expert sources is the foundation of evidence-based care, and faster answers to clinical questions through a medical search experience that is conversational, intuitive, delightful, and precise is the future of care,” said Daniel Nadler, Founder and CEO of OpenEvidence. “NEJM publishes the most trusted medical evidence in the world, and we are thrilled to establish this agreement in support of the clinicians we serve. Clinicians will benefit from answers derived from the latest invited reviews published in NEJM along with select figures, tables, and illustrations that are vital to helping doctors better understand evidence-based medical content in OpenEvidence.”
“Clinical research published in peer-reviewed academic journals is the basis of medical science, but physicians spend countless hours sifting through volumes of information,” said Dr. Antonio Jorge Forte, MD, Director of MayoExpert, Mayo Clinic. “With OpenEvidence delivering multimedia and information harvested from the leading clinical journal, clinicians can spend less time searching for and gathering information and they can spend more time with their patients.”
About OpenEvidence
OpenEvidence’s mission is to organize and expand the world’s collective medical knowledge. OpenEvidence’s first product, its eponymous medical search engine, is now used by hundreds of thousands of logged-in, verified doctors at 10,000+ care centers across the United States. Launched in 2023, OpenEvidence became the fastest platform in the history of the medical industry to surpass 100,000 verified doctor users in the United States. As of this writing, more than 25,000 verified U.S. doctors are registering for OpenEvidence each month. Aside from the iPhone, there has never been a piece of technology adopted by doctors as quickly as OpenEvidence.